Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Liau Gene | EVP Research & Preclinical Dev | Mar 02 | Option Exercise | 0.60 | 5,195 | 3,117 | 26,546 | Mar 04 05:00 PM | Liau Gene | EVP Research & Preclinical Dev | Mar 02 | Sale | 63.05 | 5,195 | 327,546 | 21,351 | Mar 04 05:00 PM | LEVIN ARTHUR A | Director | Mar 01 | Option Exercise | 0.53 | 12,500 | 6,576 | 12,500 | Mar 03 05:10 PM | LEVIN ARTHUR A | Director | Mar 01 | Sale | 60.79 | 12,500 | 759,841 | 0 | Mar 03 05:10 PM | Tulipano Stephen J | CFO | Feb 23 | Option Exercise | 4.48 | 5,000 | 22,400 | 5,602 | Feb 24 05:15 PM | Tulipano Stephen J | CFO | Feb 23 | Sale | 58.60 | 5,000 | 292,992 | 602 | Feb 24 05:15 PM | Tulipano Stephen J | CFO | Feb 22 | Option Exercise | 4.48 | 25,000 | 112,000 | 25,602 | Feb 24 05:15 PM | Tulipano Stephen J | CFO | Feb 22 | Sale | 58.92 | 25,000 | 1,472,904 | 602 | Feb 24 05:15 PM | TZIANABOS ARTHUR | Director | Feb 19 | Option Exercise | 2.19 | 10,000 | 21,900 | 10,000 | Feb 23 05:28 PM | TZIANABOS ARTHUR | Director | Feb 19 | Sale | 60.67 | 10,000 | 606,652 | 0 | Feb 23 05:28 PM | Nash Huw M. | COO & CBO | Jan 06 | Sale | 57.14 | 32 | 1,828 | 0 | Jan 06 05:26 PM | Nash Huw M. | COO & CBO | Jan 04 | Option Exercise | 2.19 | 5,700 | 12,483 | 5,732 | Jan 06 05:26 PM | Nash Huw M. | COO & CBO | Jan 04 | Sale | 58.97 | 5,700 | 336,157 | 32 | Jan 06 05:26 PM | Kaye Edward M. MD | CEO | Dec 30 | Option Exercise | 0.60 | 10,000 | 6,000 | 10,000 | Jan 04 06:33 PM | Liau Gene | EVP Research & Preclinical Dev | Dec 28 | Option Exercise | 0.60 | 8,000 | 4,800 | 21,500 | Mar 04 05:00 PM | Liau Gene | EVP Research & Preclinical Dev | Dec 28 | Sale | 58.73 | 149 | 8,751 | 21,351 | Mar 04 05:00 PM | Ticho Barry | Chief Medical Officer | Dec 21 | Option Exercise | 2.19 | 1,365 | 2,989 | 174,767 | Dec 21 04:53 PM | Ticho Barry | Chief Medical Officer | Dec 21 | Sale | 57.62 | 1,365 | 78,654 | 173,402 | Dec 21 04:53 PM | Nash Huw M. | COO & CBO | Dec 18 | Option Exercise | 0.60 | 8,015 | 4,809 | 8,015 | Dec 18 09:08 PM | Kaye Edward M. MD | CEO | Dec 18 | Sale | 60.00 | 5,194 | 311,640 | 0 | Dec 18 09:07 PM | Nash Huw M. | COO & CBO | Dec 18 | Sale | 60.00 | 8,015 | 480,900 | 0 | Dec 18 09:08 PM | Nash Huw M. | COO & CBO | Dec 17 | Option Exercise | 0.60 | 41,985 | 25,191 | 41,985 | Dec 18 09:08 PM | Kaye Edward M. MD | CEO | Dec 17 | Sale | 60.00 | 19,806 | 1,188,360 | 5,194 | Dec 18 09:07 PM | Nash Huw M. | COO & CBO | Dec 17 | Sale | 60.00 | 41,985 | 2,519,100 | 0 | Dec 18 09:08 PM | Nash Huw M. | COO & CBO | Dec 01 | Option Exercise | 2.19 | 5,700 | 12,483 | 5,700 | Dec 03 06:00 PM | Nash Huw M. | COO & CBO | Dec 01 | Sale | 49.84 | 5,700 | 284,080 | 0 | Dec 03 06:00 PM | Kaye Edward M. MD | CEO | Nov 27 | Sale | 50.00 | 12,152 | 607,600 | 25,000 | Nov 30 05:11 PM | Kaye Edward M. MD | CEO | Nov 25 | Sale | 50.00 | 12,848 | 642,400 | 37,152 | Nov 25 05:16 PM | Harrison Seth Loring | Director | Nov 24 | Buy | 39.00 | 375,000 | 14,625,000 | 17,161,713 | Nov 25 05:03 PM | Apple Tree Partners IV, L.P. | 10% Owner | Nov 24 | Buy | 39.00 | 375,000 | 14,625,000 | 17,161,713 | Nov 25 05:01 PM | TZIANABOS ARTHUR | Director | Nov 23 | Option Exercise | 2.19 | 20,000 | 43,800 | 20,000 | Nov 25 05:09 PM | TZIANABOS ARTHUR | Director | Nov 23 | Sale | 46.03 | 20,000 | 920,566 | 0 | Nov 25 05:09 PM | Nash Huw M. | COO & CBO | Nov 10 | Option Exercise | 1.03 | 50,000 | 51,328 | 50,000 | Nov 10 05:42 PM | Nash Huw M. | COO & CBO | Nov 10 | Sale | 45.00 | 50,000 | 2,250,000 | 0 | Nov 10 05:42 PM | Tulipano Stephen J | CFO | Nov 04 | Option Exercise | 4.48 | 33,268 | 149,041 | 33,870 | Nov 04 05:31 PM | Tulipano Stephen J | CFO | Nov 04 | Sale | 40.80 | 33,268 | 1,357,210 | 602 | Nov 04 05:31 PM | Tulipano Stephen J | CFO | Nov 03 | Option Exercise | 4.48 | 1,732 | 7,759 | 2,334 | Nov 04 05:31 PM | Tulipano Stephen J | CFO | Nov 03 | Sale | 39.84 | 1,732 | 68,998 | 602 | Nov 04 05:31 PM | Nash Huw M. | COO & CBO | Nov 02 | Option Exercise | 2.19 | 5,700 | 12,483 | 5,700 | Nov 04 05:30 PM | Tulipano Stephen J | CFO | Nov 02 | Option Exercise | 4.48 | 35,000 | 156,800 | 35,602 | Nov 04 05:31 PM | Tulipano Stephen J | CFO | Nov 02 | Sale | 37.25 | 35,000 | 1,303,731 | 602 | Nov 04 05:31 PM | Nash Huw M. | COO & CBO | Nov 02 | Sale | 37.21 | 5,700 | 212,110 | 0 | Nov 04 05:30 PM | Liau Gene | EVP Research & Preclinical Dev | Oct 19 | Option Exercise | 0.67 | 32,000 | 21,590 | 45,500 | Oct 20 04:52 PM | Liau Gene | EVP Research & Preclinical Dev | Oct 19 | Sale | 37.82 | 32,000 | 1,210,164 | 13,500 | Oct 20 04:52 PM | Liau Gene | EVP Research & Preclinical Dev | Oct 16 | Option Exercise | 0.60 | 5,851 | 3,511 | 19,351 | Oct 20 04:52 PM | Liau Gene | EVP Research & Preclinical Dev | Oct 16 | Sale | 40.00 | 5,851 | 234,042 | 13,500 | Oct 20 04:52 PM | Liau Gene | EVP Research & Preclinical Dev | Oct 13 | Option Exercise | 0.60 | 1,649 | 989 | 15,149 | Oct 13 05:43 PM | Liau Gene | EVP Research & Preclinical Dev | Oct 13 | Sale | 40.00 | 1,649 | 65,960 | 13,500 | Oct 13 05:43 PM | Nash Huw M. | COO & CBO | Oct 01 | Option Exercise | 2.19 | 5,700 | 12,483 | 5,700 | Oct 05 05:12 PM | Nash Huw M. | COO & CBO | Oct 01 | Sale | 34.54 | 5,700 | 196,901 | 0 | Oct 05 05:12 PM | Nash Huw M. | COO & CBO | Sep 09 | Option Exercise | 2.19 | 17,201 | 37,670 | 17,201 | Sep 10 06:21 PM | Nash Huw M. | COO & CBO | Sep 09 | Sale | 30.00 | 17,201 | 516,030 | 0 | Sep 10 06:21 PM | Nash Huw M. | COO & CBO | Sep 08 | Option Exercise | 2.19 | 30,718 | 67,272 | 30,718 | Sep 10 06:21 PM | Nash Huw M. | COO & CBO | Sep 08 | Sale | 30.00 | 30,718 | 921,540 | 0 | Sep 10 06:21 PM | Nash Huw M. | COO & CBO | Sep 01 | Option Exercise | 2.19 | 5,700 | 12,483 | 5,700 | Sep 03 06:35 PM | Nash Huw M. | COO & CBO | Sep 01 | Sale | 27.74 | 5,700 | 158,113 | 0 | Sep 03 06:35 PM | Nash Huw M. | COO & CBO | Aug 28 | Option Exercise | 2.19 | 2,081 | 4,557 | 2,081 | Aug 31 06:04 PM | Nash Huw M. | COO & CBO | Aug 28 | Sale | 30.00 | 2,081 | 62,430 | 0 | Aug 31 06:04 PM | Nash Huw M. | COO & CBO | Aug 03 | Option Exercise | 2.19 | 5,700 | 12,483 | 5,700 | Aug 04 04:59 PM | Nash Huw M. | COO & CBO | Aug 03 | Sale | 24.73 | 5,700 | 140,943 | 0 | Aug 04 04:59 PM | Nash Huw M. | COO & CBO | Jul 16 | Option Exercise | 2.19 | 1,900 | 4,161 | 1,900 | Jul 17 06:02 PM | Nash Huw M. | COO & CBO | Jul 16 | Sale | 25.06 | 1,900 | 47,614 | 0 | Jul 17 06:02 PM | Walker Robin A. | Chief Legal Officer, CCO & Sec | Jul 07 | Sale | 22.50 | 941 | 21,172 | 0 | Jul 09 05:43 PM | Nash Huw M. | COO & CBO | Jul 07 | Sale | 22.41 | 913 | 20,457 | 0 | Jul 09 05:41 PM | Nash Huw M. | COO & CBO | Jul 01 | Option Exercise | 2.19 | 3,800 | 8,322 | 3,800 | Jul 02 06:08 PM | Nash Huw M. | COO & CBO | Jul 01 | Sale | 23.15 | 3,800 | 87,968 | 0 | Jul 02 06:08 PM | Nash Huw M. | COO & CBO | Jun 01 | Option Exercise | 2.19 | 2,107 | 4,614 | 2,107 | Jun 03 04:55 PM | Liau Gene | EVP Research & Preclinical Dev | Jun 01 | Option Exercise | 2.19 | 20,000 | 43,800 | 33,500 | Jun 03 04:57 PM | Ticho Barry | Chief Medical Officer | Jun 01 | Option Exercise | 0.99 | 174,027 | 172,595 | 174,027 | Jun 03 04:58 PM | Ticho Barry | Chief Medical Officer | Jun 01 | Sale | 27.39 | 1,365 | 37,387 | 172,662 | Jun 03 04:58 PM | Liau Gene | EVP Research & Preclinical Dev | Jun 01 | Sale | 26.35 | 20,000 | 527,037 | 13,500 | Jun 03 04:57 PM | Nash Huw M. | COO & CBO | Jun 01 | Sale | 27.18 | 2,107 | 57,263 | 0 | Jun 03 04:55 PM | Liau Gene | EVP Research & Preclinical Dev | May 22 | Option Exercise | 0.60 | 7,500 | 4,500 | 21,000 | May 26 05:58 PM | Liau Gene | EVP Research & Preclinical Dev | May 22 | Sale | 30.00 | 7,500 | 225,000 | 13,500 | May 26 05:58 PM |
|